Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
McKesson Corp. pages available for free this week:
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Present Value of Free Cash Flow to Equity (FCFE)
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Price to Earnings (P/E) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to McKesson Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
---|---|---|---|---|---|---|---|
Current ratio | |||||||
Quick ratio | |||||||
Cash ratio |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
Liquidity ratio | Description | The company |
---|---|---|
Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | McKesson Corp. current ratio deteriorated from 2014 to 2015 but then slightly improved from 2015 to 2016. |
Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | McKesson Corp. quick ratio improved from 2014 to 2015 but then slightly deteriorated from 2015 to 2016 not reaching 2014 level. |
Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | McKesson Corp. cash ratio improved from 2014 to 2015 but then deteriorated significantly from 2015 to 2016. |
Current Ratio
Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Current assets | |||||||
Current liabilities | |||||||
Liquidity Ratio | |||||||
Current ratio1 | |||||||
Benchmarks | |||||||
Current Ratio, Competitors2 | |||||||
Abbott Laboratories | |||||||
Cigna Group | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Humana Inc. | |||||||
Intuitive Surgical Inc. | |||||||
Medtronic PLC | |||||||
UnitedHealth Group Inc. |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | McKesson Corp. current ratio deteriorated from 2014 to 2015 but then slightly improved from 2015 to 2016. |
Quick Ratio
Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Cash and cash equivalents | |||||||
Receivables, net | |||||||
Total quick assets | |||||||
Current liabilities | |||||||
Liquidity Ratio | |||||||
Quick ratio1 | |||||||
Benchmarks | |||||||
Quick Ratio, Competitors2 | |||||||
Abbott Laboratories | |||||||
Cigna Group | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Humana Inc. | |||||||
Intuitive Surgical Inc. | |||||||
Medtronic PLC | |||||||
UnitedHealth Group Inc. |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | McKesson Corp. quick ratio improved from 2014 to 2015 but then slightly deteriorated from 2015 to 2016 not reaching 2014 level. |
Cash Ratio
Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Cash and cash equivalents | |||||||
Total cash assets | |||||||
Current liabilities | |||||||
Liquidity Ratio | |||||||
Cash ratio1 | |||||||
Benchmarks | |||||||
Cash Ratio, Competitors2 | |||||||
Abbott Laboratories | |||||||
Cigna Group | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Humana Inc. | |||||||
Intuitive Surgical Inc. | |||||||
Medtronic PLC | |||||||
UnitedHealth Group Inc. |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | McKesson Corp. cash ratio improved from 2014 to 2015 but then deteriorated significantly from 2015 to 2016. |